ISRCTN93856392进行中(未招募)Unknown
A randomized controlled multi-centre trial investigating the effectiveness and safety of a wilderness program on the mental and physical well-being of childhood, adolescent and young adult cancer survivors
Mid Sweden University0 个研究点目标入组 150 人开始时间: 2024年1月25日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 150
研究概览
简要总结
2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38772886/ (added 22/05/2024)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current inclusion criteria as of 15/04/2024:
- •1. Adolescents and young adults (AYA) aged 16-39 years who have been diagnosed with any type of cancer during childhood, adolescence, or young adulthood
- •2. To be able to walk 2 km a day (walking aids or assistance from another person is permitted)
- •3. Participants with various disabilities and medical conditions can be included. This includes mobility impairments, amputations, vision and hearing impairments, balance problems and special treatment or dietary needs.
- •4. Prior experience with outdoor activities is not required for participation
- •Previous inclusion criteria:
- •1. Adolescents and young adults (AYA) aged 16-39 years who have been diagnosed with any type of cancer during childhood, adolescence, or young adulthood
- •2. To be able to walk 2 km without pausing (walking aids or assistance from another person is permitted)
- •3. Participants with various disabilities and medical conditions can be included. This includes mobility impairments, amputations, vision and hearing impairments, balance problems and special treatment or dietary needs.
- •4. Prior experience with outdoor activities is not required for participation
排除标准
- •1. Active cancer treatment for which participation in the study can involve unwanted risks as evaluated by the treating physician/oncologist
- •2. A medical condition that prevents safe travel to, or participation in the program
- •3. Not willing to be randomly assigned
- •4. Previous participation in the WAYA 1 study
研究者
相似试验
进行中(未招募)
不适用
Autologous stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing-remitting multiple sclerosisMultiple sclerosisRelapsing-remitting multiple sclerosisNervous System DiseasesISRCTN88667898Sheffield Teaching Hospitals NHS Foundation Trust198
进行中(未招募)
不适用
SURECAN: Survivors rehabilitation evaluation after cancerISRCTN67900293Queen Mary University of London344
进行中(未招募)
2 期
Effects of external trigeminal nerve stimulation in ADHD and mechanisms of actioISRCTN82129325King's College London150
已完成
不适用
Cluster randomised trial to evaluate an intervention for depressed HIV-positive women in the perinatal period, to enhance child development and reduce maternal depressioPerinatal depression in women with HIV infectionMental and Behavioural DisordersISRCTN11284870The University of Oxford320
已完成
不适用
The impact of pausing BTKi therapy and responsiveness of vaccination in blood cancer patients: A randomised controlled study – the IMPROVE studyChronic lymphocytic leukaemiaCancerISRCTN14197181niversity of Birmingham99
